# Stackr vs Reve

The clearest difference is rating: Reve at 5.0 against Stackr's 4.4. Stackr's advantage is monetization model (freemium vs subscription) and ratings volume (215 vs 4). On price, update cadence, ads and in-app purchases there is nothing between them.

Both are free to download. Stackr sells 7 in-app purchases, starting at $7.99 per 7 days and Reve sells 2 in-app purchases, starting at $24.99 per month. Whichever you choose, the download price is not the number that matters.

Reve holds the better App Store score, 5.0 against 4.4. That said, the two scores are not equally well evidenced: Stackr has 215 ratings behind it against 4, so its average is the more settled of the two.

Both ship on a similar rhythm, roughly weekly. The most recent releases landed on November 5, 2026 and November 6, 2026 respectively.

## The numbers

| Metric | Stackr | Reve |
| --- | --- | --- |
| Price | Free | Free |
| Rating | [4.4 (215 ratings)](https://appshunter.io/ios/app/stackr-peptide-glp-1-tracker/id6764821587/reviews) | **[5.0 (4 ratings)](https://appshunter.io/ios/app/reve-peptide-and-cycle-tracker/id6810085933/reviews)** |
| Number of ratings | **215** | 4 |
| Positive reviews | 67.6% of reviews | — |
| In-app purchases | Yes | Yes |
| Ads | No | No |
| Update frequency | Weekly | Weekly |
| Monetization | **Freemium** | Subscription |
| Best chart rank | **#185** | — |
| Size | 88 MB | 27 MB |
| Requires iOS | 17.0 | 17.0 |
| Devices | iPhone | iPhone |
| Age rating | 12+ | 17+ |
| Developer | [Stackr Holdings LLC](https://appshunter.io/developer/1896525659) | [Reve Health](https://appshunter.io/developer/6810085935) |

## What reviewers say

### Stackr

[App page](https://appshunter.io/ios/app/stackr-peptide-glp-1-tracker/id6764821587)

**Currently charting:** #185 Top Free · Health & Fitness (US App Store)

This app simplifies tracking peptide and GLP-1 doses, including supplies like vials and pens. It offers smart reminders, home screen widgets, and visual charts of estimated active levels based on half-life. Designed for users managing peptide protocols, it keeps your dosing information organized and accessible.

**Highlights:** Log peptide and GLP-1 doses, Track vials, pens, and other supplies, Smart reminders for next doses, Home screen widgets, Estimated active level charts, Multi-peptide stack tracking, Reference pages for common compounds

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases (7)**

| Purchase | Price | Billing |
| --- | --- | --- |
| Stackr+ Weekly | $7.99 | per 7 days |
| Monthly | $12.99 | per month |
| Stackr+ Yearly | $29.99 | per year |
| Stackr+ Yearly | $49.99 | per year |
| Stackr+ Yearly | $49.99 | per year |
| Stackr+ Yearly | $59.99 | per year |
| Yearly | $69.99 | per year |


### Reve

[App page](https://appshunter.io/ios/app/reve-peptide-and-cycle-tracker/id6810085933)

This app helps women track their peptide doses and symptoms alongside their menstrual cycle. Log your protocol, doses, and how you feel, then view patterns organized by cycle phase. It provides reference material on common compounds.

**Highlights:** Build and log peptide protocols, Track doses with reminders, Log mood, energy, and sleep, Monitor measurements and progress photos, Organize data by cycle phase, Access compound reference material

**Features:** Vision Pro support

**In-app purchases (2)**

| Purchase | Price | Billing |
| --- | --- | --- |
| Monthly | $24.99 | per month |
| 3 Months | $69.99 | per 3 months |


## Frequently asked questions

### Is Stackr free?

Stackr is free to download, with in-app purchases available.

### Is Reve free?

Reve is free to download, with in-app purchases available.

### Which has better reviews, Stackr or Reve?

Reve is rated higher. Stackr averages 4.4 out of 5 from 215 ratings, while Reve averages 5.0 from 4 ratings.

### Do Stackr or Reve have ads?

Neither Stackr nor Reve shows ads.

### Which is updated more often, Stackr or Reve?

Stackr ships an update weekly, and Reve weekly. Most recently, Stackr was updated on November 5, 2026 and Reve on November 6, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*